Printed From:

First Treatment of Its Kind

DUPIXENT is the first biologic for adults with uncontrolled moderate-to-severe atopic dermatitis.

Self Injectable, Inhibitor
of
IL-4 and IL-13
Signaling
For Adult Patients with
Moderate-to-Severe
Atopic Dermatitis

 

About
DUPIXENT

DUPIXENT is indicated for the treatment of adult patients with
moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.


DUPIXENT can be used with or without topical corticosteroids.


Request a Field Representative Visit

 

DUPIXENT MyWay™

The DUPIXENT MyWayTM program offers your patients support in navigating reimbursement, help with covering the cost of DUPIXENT and educational services.